Table 1 Baseline characteristics of the study participants
Characteristics | Asthma (n = 10) | Control (n = 9) |
|---|---|---|
Age (years) | 33.5 (28.8, 38.0) | 35 (34, 38) |
Gender (male, %) | 50.0 | 55.5 |
Body mass index (BMI, kg/m2) | 23.6 (21.6, 25.7) | 23.7 (21.3, 25.8) |
Pulse oximetry saturation (SpO2, %) | 97.0 ( 96.0, 97.3) | 99.0 (98.5, 99.0)*** |
Current/ex-smoker | 1 | 0 |
Blood white blood cells count (cells/μL) | 5300.0 (4700, 7400) | 5770.0 (5130.0, 7370) |
Blood eosinophils count (cells/μL) | 150.0 (135, 220) | 290 (180.0, 415) |
Blood eosinophils (%) | 4.0 (2.5, 4.5) | 4.0 (3.2, 8.5) |
Blood basophils (%) | 0.0 (0.0, 0.2) | 0.4 (0.4, 0.8)** |
Blood neutrophils (%) | 62.8 (58.6, 66.9) | 59.0 (57.3, 60.9) |
Blood lymphocytes (%) | 28.6 (26.4, 35.6) | 28.3 (26.9, 32.7) |
Blood monocytes (%) | 4.0 (2.5, 4.5) | 5.2 (3.2, 5.7) |
Forced expiratory volume in 1Â s (FEV1, L) | 3.1 (2.8, 3.6) | 3.3 (2.7, 3.7) |
FEV1% pred (%) | 84.4 (74.8, 102.4) | 96.0 (92.5, 103.5) |
FEV1/forced vital capacity (FVC) (%) | 84.4 (74.8, 102.4) | 83.4 (77.7, 88.2) |
Fractional exhaled nitric oxide (FeNO, bbp) | 72.0 (23.0, 128.3) | 12.0 (10.0, 29.0)* |
Asthma control test (ACT) score | 20 (19, 23) | NA |
Asthma control questionnaire-7 (ACQ-7) score | 0.7 (0.6, 1.0) | NA |
Medication status | Â | Â |
 Short-acting beta-2 agonist (SABA) | 3 | 0 |
 Long-acting beta-2 agonist (LABA) | 0 | 0 |
 Long-acting muscarinic antagonist (LAMA) | 0 | 0 |
 LABA + inhaled corticosteroid (ICS) | 1 | 0 |
 LAMA + ICS | 7 | 0 |
 Theophylline | 1 | 0 |